149 related articles for article (PubMed ID: 22690075)
21. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus-related hepatocellular carcinoma presenting at an advanced stage: is it preventable?
Mules T; Gane E; Lithgow O; Bartlett A; McCall J
N Z Med J; 2018 Nov; 131(1486):27-35. PubMed ID: 30496164
[TBL] [Abstract][Full Text] [Related]
23. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
Cheong JY; Shin HD; Cho SW; Kim YJ
J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
[TBL] [Abstract][Full Text] [Related]
24. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of the risk factors of hepatocellular carcinoma in cirrhotic patients with chronic hepatitis B].
Zhang Y; Peng L; Cao Y; Zeng Z; Wu Y; Shi H; Chen S; Guo J
Zhonghua Gan Zang Bing Za Zhi; 2015 Jul; 23(7):512-6. PubMed ID: 26398842
[TBL] [Abstract][Full Text] [Related]
26. Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance.
Kumagi T; Terao T; Yokota T; Azemoto N; Kuroda T; Imamura Y; Uesugi K; Kisaka Y; Tanaka Y; Shibata N; Koizumi M; Ohno Y; Yukimoto A; Tange K; Nishiyama M; Kanemitsu K; Miyake T; Miyata H; Ishii H; Hiasa Y;
Mayo Clin Proc; 2019 Oct; 94(10):2004-2010. PubMed ID: 31262521
[TBL] [Abstract][Full Text] [Related]
27. Clinical course of sub-centimeter-sized nodules detected during surveillance for hepatocellular carcinoma.
Min YW; Gwak GY; Lee MW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
World J Gastroenterol; 2012 Jun; 18(21):2654-60. PubMed ID: 22690074
[TBL] [Abstract][Full Text] [Related]
28. Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease.
Shoji B; Ikeda F; Fujioka S; Kobashi H; Yasunaka T; Miyake Y; Shiraha H; Takaki A; Nouso K; Iwasaki Y; Yamamoto K
J Gastroenterol; 2010 Nov; 45(11):1172-82. PubMed ID: 20549250
[TBL] [Abstract][Full Text] [Related]
29. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
Poh Z; Goh BB; Chang PE; Tan CK
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):638-43. PubMed ID: 25831135
[TBL] [Abstract][Full Text] [Related]
30. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
31. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of hepatitis B core-related antigen in chronic hepatitis B and hepatocellular carcinoma patients.
Chen S; Jia J; Gao Y; Li H; Fang M; Feng H; Guan W; Ji J; Gao Z; Gao C
Clin Chim Acta; 2018 Nov; 486():237-244. PubMed ID: 30025756
[TBL] [Abstract][Full Text] [Related]
33. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
34. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
35. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
36. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
37. Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study.
Romano A; Angeli P; Piovesan S; Noventa F; Anastassopoulos G; Chemello L; Cavalletto L; Gambato M; Russo FP; Burra P; Vincenzi V; Scotton PG; Panese S; Tempesta D; Bertin T; Carrara M; Carlotto A; Capra F; Carolo G; Scroccaro G; Alberti A
J Hepatol; 2018 Aug; 69(2):345-352. PubMed ID: 29551707
[TBL] [Abstract][Full Text] [Related]
38. Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease.
An C; Choi YA; Choi D; Paik YH; Ahn SH; Kim MJ; Paik SW; Han KH; Park MS
Clin Mol Hepatol; 2015 Sep; 21(3):279-86. PubMed ID: 26523271
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B.
Zhang YQ; Peng LJ; Cao YR; Zeng ZP; Wu YJ; Shi H; Cheng SY; Wang JY; Friedman SL; Sninsky JJ; Guo JS
Genet Test Mol Biomarkers; 2016 Sep; 20(9):535-43. PubMed ID: 27391584
[TBL] [Abstract][Full Text] [Related]
40. The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.
Hassan MM; Spitz MR; Thomas MB; Curley SA; Patt YZ; Vauthey JN; Glover KY; Kaseb A; Lozano RD; El-Deeb AS; Nguyen NT; Wei SH; Chan W; Abbruzzese JL; Li D
J Hepatol; 2009 Feb; 50(2):334-41. PubMed ID: 19070394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
